Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-27
2005-09-27
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S084000, C206S570000, C544S333000, C544S362000, C544S405000
Reexamination Certificate
active
06949562
ABSTRACT:
Disclosed are heterocyclic compounds of the formulaand the pharmaceutically acceptable salts thereof wherein the variables A, V, Y, J, E, X, T, G, Q, W, Z, b, n and m are defined herein. These compounds are highly selective agonists, antagonists or inverse agonists for GABAAbrain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAAbrain receptor.
REFERENCES:
patent: 5344826 (1994-09-01), Covey et al.
patent: 5723462 (1998-03-01), Albaugh et al.
patent: WO 98/50384 (1998-11-01), None
patent: WO 98/50385 (1998-11-01), None
patent: WO 99/00391 (1999-01-01), None
patent: WO 99/29319 (1999-06-01), None
patent: WO 99/43681 (1999-09-01), None
patent: WO 99/43682 (1999-09-01), None
Leusink, et al., (1992),J. Chem. Soc., Chem. Commun.,pp. 1401-1402.
Currie Kevin
Ghosh Manuka
Lee Kyungae
Liu Xiaojun
Luke George
Habte Kahsay
McDonnell Boehnen & Hulbert & Berghoff LLP
Neurogen Corporation
Pfizer Inc.
Wilson James O.
LandOfFree
Heterocyclic compounds as ligands of the GABAA receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds as ligands of the GABAA receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds as ligands of the GABAA receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3372868